Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 94 entries
View as:

A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Phase: N/A Priority: Normal
NCT ID: NCT02218372 Org: User:
Start: 01/09/15 End: 03/07/18 Due: 03/07/19

A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00902928 Org: User:
Start: 04/30/09 End: 08/31/10 Due: 08/31/11

A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain

Phase: N/A Priority: Normal
NCT ID: NCT01767090 Org: User:
Start: 12/04/12 End: 07/30/15 Due: 07/30/16

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01021332 Org: User:
Start: 04/26/10 End: 12/14/11 Due: 12/14/12

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01018511 Org: User:
Start: 01/11/10 End: 03/01/11 Due: 03/01/12

Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents

Phase: N/A Priority: Normal
NCT ID: NCT01686607 Org: User:
Start: 10/01/12 End: 04/30/18 Due: 04/30/19

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3700 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02285465 Org: User:
Start: 11/30/14 End: 11/30/14 Due: 11/30/15

A Study to Evaluate the Effect of ASP1707 on the Bodies of Healthy Male Subjects After a Single Dose of Radioactive ASP1707

Phase: N/A Priority: Normal
NCT ID: NCT02106780 Org: User:
Start: 08/31/11 End: 09/30/11 Due: 09/30/12

A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02359032 Org: User:
Start: 01/31/15 End: 01/31/16 Due: 01/31/17

A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02358096 Org: User:
Start: 03/17/15 End: 03/15/17 Due: 03/15/18

A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)

Phase: N/A Priority: Normal
NCT ID: NCT01981954 Org: User:
Start: 09/25/13 End: 12/18/15 Due: 12/18/16

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT01604928 Org: User:
Start: 04/05/04 End: 01/25/05 Due: 01/25/06

Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01902251 Org: User:
Start: 11/30/12 End: 10/31/13 Due: 10/31/14

Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02110394 Org: User:
Start: 06/30/12 End: 08/31/15 Due: 08/31/16

A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics

Phase: N/A Priority: Normal
NCT ID: NCT02087098 Org: User:
Start: 06/30/14 End: 03/31/16 Due: 03/31/17

Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and Itraconazole

Phase: N/A Priority: Normal
NCT ID: NCT01913379 Org: User:
Start: 08/31/11 End: 12/31/11 Due: 12/31/12

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02218099 Org: User:
Start: 09/16/13 End: 09/09/14 Due: 09/09/15

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Phase: N/A Priority: Normal
NCT ID: NCT02526979 Org: User:
Start: 12/17/15 End: 09/30/16 Due: 09/30/17

A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety

Phase: N/A Priority: Normal
NCT ID: NCT02065349 Org: User:
Start: 02/24/14 End: 02/13/15 Due: 02/13/16

A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT01340027 Org: User:
Start: 03/29/11 End: 06/28/12 Due: 06/28/13

A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin

Phase: N/A Priority: Normal
NCT ID: NCT02794792 Org: User:
Start: 05/11/16 End: 06/20/17 Due: 06/20/18

A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01943487 Org: User:
Start: 08/31/09 End: 12/31/09 Due: 12/31/10

A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02083627 Org: User:
Start: 02/28/13 End: 03/31/13 Due: 03/31/14

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT02045862 Org: User:
Start: 03/17/14 End: 09/08/16 Due: 09/08/17

A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01911741 Org: User:
Start: 11/30/12 End: 03/31/13 Due: 03/31/14